624 related articles for article (PubMed ID: 30877925)
1. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
[TBL] [Abstract][Full Text] [Related]
3. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
5. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
6. Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ.
Waddington KE; Papadaki A; Coelewij L; Adriani M; Nytrova P; Kubala Havrdova E; Fogdell-Hahn A; Farrell R; Dönnes P; Pineda-Torra I; Jury EC
Front Immunol; 2020; 11():1527. PubMed ID: 32765529
[No Abstract] [Full Text] [Related]
7. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
[TBL] [Abstract][Full Text] [Related]
8. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
[TBL] [Abstract][Full Text] [Related]
9. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients.
Solmaz İ; Kaplan O; Çelebier M; Lay İ; Anlar B
Turk J Med Sci; 2022 Aug; 52(4):1299-1310. PubMed ID: 36326407
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
11. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling.
Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H
J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Profiling of Plasma from Melioidosis Patients Using UHPLC-QTOF MS Reveals Novel Biomarkers for Diagnosis.
Lau SK; Lee KC; Lo GC; Ding VS; Chow WN; Ke TY; Curreem SO; To KK; Ho DT; Sridhar S; Wong SC; Chan JF; Hung IF; Sze KH; Lam CW; Yuen KY; Woo PC
Int J Mol Sci; 2016 Feb; 17(3):307. PubMed ID: 26927094
[TBL] [Abstract][Full Text] [Related]
13. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.
Bhargava P; Fitzgerald KC; Calabresi PA; Mowry EM
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978801
[TBL] [Abstract][Full Text] [Related]
14. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
Abu Bakar MH; Sarmidi MR
Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics of Multiple Sclerosis Lesions Demonstrates Lipid Changes Linked to Alterations in Transcriptomics-Based Cellular Profiles.
Ladakis DC; Pedrini E; Reyes-Mantilla MI; Sanjayan M; Smith MD; Fitzgerald KC; Pardo CA; Reich DS; Absinta M; Bhargava P
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200219. PubMed ID: 38547430
[TBL] [Abstract][Full Text] [Related]
16. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.
Wang J; Yan D; Zhao A; Hou X; Zheng X; Chen P; Bao Y; Jia W; Hu C; Zhang ZL; Jia W
Osteoporos Int; 2019 Jul; 30(7):1491-1499. PubMed ID: 30778642
[TBL] [Abstract][Full Text] [Related]
18. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
19. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
